A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia
A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia
The main purpose of this study is to evaluate the efficacy of the study drug known as lanabecestat in participants with mild Alzheimer's disease (AD) dementia.
Inclusion Criteria:
Exclusion Criteria:
Saint Priest En Jarez, Pays de la Loire Region 42270, France
Anjo-shi, Aichi-ken 446-8510, Japan
Toon-Shi, Ehime 791-0295, Japan
Shirakawa-shi, Fukushima 961-0021, Japan
Otaki-Shi, Hiroshima 739-0696, Japan
Uji-Shi, Kyoto 611-0021, Japan
Yufu-shi, Oita Prefecture 879-5593, Japan
Kurashiki-shi, Okayama-ken 710-0813, Japan
Suita-shi, Osaka 565-0874, Japan
Kanzaki-gun, Saga-ken 842-0192, Japan
Bunkyo-ku, Tokyo 113-0034, Japan
Bunkyo-ku, Tokyo 113-8431, Japan
Hachioji-shi, Tokyo-To 192-0071, Japan
Yonago-shi, Tottori 683-8605, Japan
Bucheon-si, Gyeonggi-do 14647, South Korea